Established since 2007, AnyGenes® is privately owned biotechnology company. Involved in research and development, manufacturing, production and sales of signaling pathways for biomarkers discovery and validation.
They represent signaling pathways (SignArrays®)
of different cellular processes (cell cycle, apoptosis, autophagy, drug resistance, drug metabolism...), and for severe disease (cancer, neurodegenerative disease, autoimmune diseases…), specifically designed to be analysed by qPCR array technology and dedicated (home designed) software data analysis. AnyGenes® products are bench controlled, easy to use, and cost effective.